SE0401763D0 - Compounds - Google Patents

Compounds

Info

Publication number
SE0401763D0
SE0401763D0 SE0401763A SE0401763A SE0401763D0 SE 0401763 D0 SE0401763 D0 SE 0401763D0 SE 0401763 A SE0401763 A SE 0401763A SE 0401763 A SE0401763 A SE 0401763A SE 0401763 D0 SE0401763 D0 SE 0401763D0
Authority
SE
Sweden
Prior art keywords
sup
compounds
pharmaceutical compositions
therapy
preparing
Prior art date
Application number
SE0401763A
Other languages
English (en)
Inventor
Balint Gabos
Lena Ripa
Kristina Stenvall
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0401763A priority Critical patent/SE0401763D0/sv
Publication of SE0401763D0 publication Critical patent/SE0401763D0/sv
Priority to TW094121767A priority patent/TW200605888A/zh
Priority to SA5260190A priority patent/SA05260190B1/ar
Priority to PCT/SE2005/001093 priority patent/WO2006004533A1/en
Priority to EP05755334A priority patent/EP1794147A1/en
Priority to BRPI0512986-9A priority patent/BRPI0512986A/pt
Priority to CNA200580022806XA priority patent/CN1980915A/zh
Priority to AU2005260143A priority patent/AU2005260143B2/en
Priority to US11/571,643 priority patent/US20080004317A1/en
Priority to KR1020077000187A priority patent/KR20070038498A/ko
Priority to JP2007520268A priority patent/JP2008505172A/ja
Priority to MXPA06014663A priority patent/MXPA06014663A/es
Priority to CA002569727A priority patent/CA2569727A1/en
Priority to UY29003A priority patent/UY29003A1/es
Priority to ARP050102792A priority patent/AR049577A1/es
Priority to IL179907A priority patent/IL179907A0/en
Priority to ZA200610701A priority patent/ZA200610701B/xx
Priority to NO20070570A priority patent/NO20070570L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
SE0401763A 2004-07-05 2004-07-05 Compounds SE0401763D0 (sv)

Priority Applications (18)

Application Number Priority Date Filing Date Title
SE0401763A SE0401763D0 (sv) 2004-07-05 2004-07-05 Compounds
TW094121767A TW200605888A (en) 2004-07-05 2005-06-29 Novel compounds
SA5260190A SA05260190B1 (ar) 2004-07-05 2005-06-29 مشتقات هيدانتيون Hydantoin وعمليات لتحضيرها وتركيبات صيدلانية محتوية عليها واستخدامها
CA002569727A CA2569727A1 (en) 2004-07-05 2005-07-04 Compounds
US11/571,643 US20080004317A1 (en) 2004-07-05 2005-07-04 Compounds
JP2007520268A JP2008505172A (ja) 2004-07-05 2005-07-04 化合物
BRPI0512986-9A BRPI0512986A (pt) 2004-07-05 2005-07-04 novos derivados de hidantoìna
CNA200580022806XA CN1980915A (zh) 2004-07-05 2005-07-04 化合物
AU2005260143A AU2005260143B2 (en) 2004-07-05 2005-07-04 Compounds
PCT/SE2005/001093 WO2006004533A1 (en) 2004-07-05 2005-07-04 Compounds
KR1020077000187A KR20070038498A (ko) 2004-07-05 2005-07-04 화합물
EP05755334A EP1794147A1 (en) 2004-07-05 2005-07-04 Compounds
MXPA06014663A MXPA06014663A (es) 2004-07-05 2005-07-04 Compuestos derivados de hdantoina.
ARP050102792A AR049577A1 (es) 2004-07-05 2005-07-05 Derivados de hidantoina, procesos para su preparacion, composiciones y su uso
UY29003A UY29003A1 (es) 2004-07-05 2005-07-05 Nuevos derivados de hidantoína, procesos para su preparación, composiciones farmacéuticas que los contienen y su uso en terapia
IL179907A IL179907A0 (en) 2004-07-05 2006-12-07 Compounds
ZA200610701A ZA200610701B (en) 2004-07-05 2006-12-19 Compounds
NO20070570A NO20070570L (no) 2004-07-05 2007-01-30 Forbindelser.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0401763A SE0401763D0 (sv) 2004-07-05 2004-07-05 Compounds

Publications (1)

Publication Number Publication Date
SE0401763D0 true SE0401763D0 (sv) 2004-07-05

Family

ID=32768774

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0401763A SE0401763D0 (sv) 2004-07-05 2004-07-05 Compounds

Country Status (18)

Country Link
US (1) US20080004317A1 (sv)
EP (1) EP1794147A1 (sv)
JP (1) JP2008505172A (sv)
KR (1) KR20070038498A (sv)
CN (1) CN1980915A (sv)
AR (1) AR049577A1 (sv)
AU (1) AU2005260143B2 (sv)
BR (1) BRPI0512986A (sv)
CA (1) CA2569727A1 (sv)
IL (1) IL179907A0 (sv)
MX (1) MXPA06014663A (sv)
NO (1) NO20070570L (sv)
SA (1) SA05260190B1 (sv)
SE (1) SE0401763D0 (sv)
TW (1) TW200605888A (sv)
UY (1) UY29003A1 (sv)
WO (1) WO2006004533A1 (sv)
ZA (1) ZA200610701B (sv)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0100903D0 (sv) * 2001-03-15 2001-03-15 Astrazeneca Ab Compounds
SE0100902D0 (sv) * 2001-03-15 2001-03-15 Astrazeneca Ab Compounds
SE0202539D0 (sv) 2002-08-27 2002-08-27 Astrazeneca Ab Compounds
SE0401762D0 (sv) * 2004-07-05 2004-07-05 Astrazeneca Ab Novel compounds
US7648992B2 (en) * 2004-07-05 2010-01-19 Astrazeneca Ab Hydantoin derivatives for the treatment of obstructive airway diseases
SE0403086D0 (sv) * 2004-12-17 2004-12-17 Astrazeneca Ab Compounds
SE0403085D0 (sv) * 2004-12-17 2004-12-17 Astrazeneca Ab Novel componds
MX2007011378A (es) * 2005-03-16 2008-03-18 Sensus Metering Systems Inc Metodo, sistema, aparato y producto de programa de computadora para determinar la ubicacion fisica de un sensor.
TW200740769A (en) * 2006-03-16 2007-11-01 Astrazeneca Ab Novel process
TW200831488A (en) * 2006-11-29 2008-08-01 Astrazeneca Ab Novel compounds
WO2009007747A2 (en) * 2007-07-11 2009-01-15 Astrazeneca Ab Hydantoin derivatives used as mmp12 inhibitors
WO2010090680A1 (en) 2008-12-15 2010-08-12 Wyeth Llc Substituted oxindole cb2 agonists
EP3321256A4 (en) * 2015-07-09 2019-04-03 Mitsubishi Tanabe Pharma Corporation NOVEL IMIDE DERIVATIVES AND THEIR USE AS A MEDICINE
IT201700026858A1 (it) * 2017-03-10 2018-09-10 Univ Degli Studi Padova Uso di inibitori delle serin proteasi, in particolare di serpinb3

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9815882A (pt) * 1998-06-03 2002-09-17 Gpi Nil Holding Inc Sulfonamidas ligadas por n de ácido carboxìlicos n-heterocìclicos ouou de isósteros de ácidos carboxìlicos
JP2002518368A (ja) * 1998-06-17 2002-06-25 デュポン ファーマシューティカルズ カンパニー メタロプロテイナーゼ阻害剤としての環式ヒドロキサム酸類
US6340691B1 (en) * 1999-01-27 2002-01-22 American Cyanamid Company Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase and tace inhibitors
DE60026404T2 (de) * 1999-08-02 2006-10-19 F. Hoffmann-La Roche Ag Verfahren zur Herstellung von Benzothiophen-Derivaten
US20020091107A1 (en) * 2000-09-08 2002-07-11 Madar David J. Oxazolidinone antibacterial agents
SE0100902D0 (sv) * 2001-03-15 2001-03-15 Astrazeneca Ab Compounds
SE0100903D0 (sv) * 2001-03-15 2001-03-15 Astrazeneca Ab Compounds
WO2002074750A1 (en) * 2001-03-15 2002-09-26 Astrazeneca Ab Metalloproteinase inhibitors
WO2002096426A1 (en) * 2001-05-25 2002-12-05 Bristol-Myers Squibb Company Hydantion derivatives as inhibitors of matrix metalloproteinases
GB0114004D0 (en) * 2001-06-08 2001-08-01 Glaxo Group Ltd Chemical compounds
SE0103710D0 (sv) * 2001-11-07 2001-11-07 Astrazeneca Ab Compounds
SE0202539D0 (sv) * 2002-08-27 2002-08-27 Astrazeneca Ab Compounds
SE0202693D0 (sv) * 2002-09-11 2002-09-11 Astrazeneca Ab Compounds
GB0221250D0 (en) * 2002-09-13 2002-10-23 Astrazeneca Ab Compounds
GB0221246D0 (en) * 2002-09-13 2002-10-23 Astrazeneca Ab Compounds
TWI220073B (en) * 2003-07-24 2004-08-01 Au Optronics Corp Method for manufacturing polysilicon film
SE0401762D0 (sv) * 2004-07-05 2004-07-05 Astrazeneca Ab Novel compounds

Also Published As

Publication number Publication date
UY29003A1 (es) 2006-02-24
AR049577A1 (es) 2006-08-16
CN1980915A (zh) 2007-06-13
BRPI0512986A (pt) 2008-04-22
WO2006004533A1 (en) 2006-01-12
MXPA06014663A (es) 2007-02-12
CA2569727A1 (en) 2006-01-12
EP1794147A1 (en) 2007-06-13
SA05260190B1 (ar) 2008-03-26
JP2008505172A (ja) 2008-02-21
TW200605888A (en) 2006-02-16
ZA200610701B (en) 2008-08-27
KR20070038498A (ko) 2007-04-10
AU2005260143B2 (en) 2009-01-29
IL179907A0 (en) 2007-05-15
NO20070570L (no) 2007-04-10
AU2005260143A1 (en) 2006-01-12
US20080004317A1 (en) 2008-01-03

Similar Documents

Publication Publication Date Title
SE0300480D0 (sv) Novel compounds
MY145613A (en) Novel compounds
SE0200920D0 (sv) Novel compounds
TW200613243A (en) Novel compounds
SE0202539D0 (sv) Compounds
SE0104140D0 (sv) Novel Compounds
TW200801003A (en) Novel compounds
SE0301700D0 (sv) Novel compounds
TW200605888A (en) Novel compounds
SE0302811D0 (sv) Novel compounds
PT1263725E (pt) Novos compostos
TW200626553A (en) Novel compounds
TW200800999A (en) Novel compounds
MX2009005357A (es) Derivados de hidantoina usados como inhibidores de metaloproteinasas de matriz.
IS2376B (is) Þíenópýrimidíndíón og notkun þeirra í breytingu ásjálfsnæmissjúkdómi
TW200738659A (en) Novel compounds
SE0302139D0 (sv) Novel compounds
TW200833670A (en) Novel compounds 569
TW200639156A (en) New compounds
TW200635917A (en) Novel compounds
MX2010009022A (es) Derivados 16 alfa, 17 alfa-acetal glucocorticoesteroideos y su uso.
MX2009006010A (es) Derivados de amina y su uso en enfermedades mediadas por el adrenoreceptor beta 2.
SE0302192D0 (sv) Novel compounds
TW200635916A (en) Compounds
TW200740781A (en) Novel compounds